INTRA CELLULAR THERAPIES INC's ticker is ITCI and the CUSIP is 46116X101. A total of 336 filers reported holding INTRA CELLULAR THERAPIES INC in Q4 2023. The put-call ratio across all filers is 0.43 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $15,232,176 | +227517.7% | 222,400 | +130.0% | 0.03% | +136.4% |
Q1 2024 | $6,692 | -38.7% | 96,700 | -36.5% | 0.01% | -35.3% |
Q4 2023 | $10,915 | -20.6% | 152,400 | -42.3% | 0.02% | -26.1% |
Q3 2023 | $13,752 | -9.7% | 264,000 | +9.8% | 0.02% | +4.5% |
Q2 2023 | $15,228 | -99.3% | 240,500 | +58.9% | 0.02% | +1000.0% |
Q1 2020 | $2,327,000 | +117.9% | 151,400 | +84.0% | 0.00% | +100.0% |
Q2 2019 | $1,068,000 | +4.5% | 82,300 | -1.9% | 0.00% | 0.0% |
Q1 2019 | $1,022,000 | -35.8% | 83,900 | -40.0% | 0.00% | -50.0% |
Q4 2018 | $1,592,000 | +58.1% | 139,800 | +201.3% | 0.00% | +100.0% |
Q3 2018 | $1,007,000 | -94.2% | 46,400 | -94.7% | 0.00% | -88.9% |
Q2 2018 | $17,223,000 | +50.1% | 870,476 | +59.7% | 0.01% | -30.8% |
Q1 2018 | $11,472,000 | +37.7% | 545,000 | -5.3% | 0.01% | +44.4% |
Q4 2017 | $8,330,000 | +31.5% | 575,300 | +43.3% | 0.01% | +28.6% |
Q3 2017 | $6,337,000 | +103.6% | 401,600 | +60.3% | 0.01% | +75.0% |
Q2 2017 | $3,112,000 | -30.6% | 250,600 | -9.2% | 0.00% | -33.3% |
Q1 2017 | $4,485,000 | -31.0% | 276,000 | +18.0% | 0.01% | -50.0% |
Q1 2016 | $6,502,000 | +170.5% | 233,900 | +423.3% | 0.01% | +140.0% |
Q4 2015 | $2,404,000 | -67.2% | 44,700 | -75.6% | 0.01% | -70.6% |
Q3 2015 | $7,331,000 | +613.8% | 183,091 | +325.8% | 0.02% | +750.0% |
Q1 2015 | $1,027,000 | – | 43,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
DCF Advisers, LLC | 375,000 | $15,308,000 | 5.42% |
SILVERARC CAPITAL MANAGEMENT, LLC | 113,258 | $4,623,000 | 2.06% |
Tri Locum Partners LP | 150,783 | $6,155,000 | 2.02% |
COOPER/HAIMS ADVISORS, LLC | 61,116 | $2,495,000 | 1.64% |
Vantage Consulting Group Inc | 226,670 | $9,252,000 | 1.61% |
Nicholas Investment Partners, LP | 598,261 | $24,421,000 | 1.53% |
Bellevue Group AG | 3,609,919 | $147,357,000 | 1.44% |
GENERAL AMERICAN INVESTORS CO INC | 350,804 | $14,320,000 | 1.20% |
Rhenman & Partners Asset Management AB | 429,728 | $17,541,000 | 1.19% |
WASATCH ADVISORS LP | 6,506,789 | $265,607,000 | 1.08% |